Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-12,942
Closed -$311K – 2649
2019
Q4
$311K Sell
12,942
-2,852
-18% -$65.1K ﹤0.01% 2051
2019
Q3
$333K Buy
15,794
+5,311
+51% +$110K ﹤0.01% 2120
2019
Q2
$231K Buy
+10,483
New +$243K ﹤0.01% 2052
2017
Q3
– Sell
-20,304
Closed -$538K – 2607
2017
Q2
$538K Buy
+20,304
New +$542K ﹤0.01% 1579
2015
Q3
– Sell
-8,283
Closed -$248K – 2986
2015
Q2
$248K Buy
+8,283
New +$233K ﹤0.01% 1868

Other funds holding TBI

Jefferies Group's TBI Position: Q1 2020 in Review

Jefferies Group sold out of Trueblue (TBI) in Q1 2020, closing a stake of 12,942 shares — an estimated $311K sold.

Jefferies Group first reported a position in TBI in Q2 2015 and held it in 5 quarters. The position peaked at $538K in Q2 2017. 157 funds tracked by Wall St. Rank hold TBI as of Q1 2020.

  • Jefferies Group reported no remaining Trueblue position as of Q1 2020 after selling out during the quarter.
  • Jefferies Group sold 12,942 Trueblue shares in Q1 2020, an estimated $311K.
  • Jefferies Group first reported a position in Trueblue in Q2 2015 and held it in 5 quarters.
  • Jefferies Group's Trueblue position peaked at $538K in Q2 2017.
  • 157 funds tracked by Wall St. Rank held Trueblue as of Q1 2020.

Based on Jefferies Group's 13F filing for Q1 2020, filed 15 May 2020.